RS49756B - Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija - Google Patents

Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija

Info

Publication number
RS49756B
RS49756B YUP-654/01A YUP65401A RS49756B RS 49756 B RS49756 B RS 49756B YU P65401 A YUP65401 A YU P65401A RS 49756 B RS49756 B RS 49756B
Authority
RS
Serbia
Prior art keywords
xenon
preparing
pharmaceutical preparation
neurointoxications
treating
Prior art date
Application number
YUP-654/01A
Other languages
English (en)
Inventor
Christian Petzelt
Wolfgang Kox
Original Assignee
Air Products And Chemicals Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7900688&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49756(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Air Products And Chemicals Inc., filed Critical Air Products And Chemicals Inc.,
Publication of YU65401A publication Critical patent/YU65401A/sh
Publication of RS49756B publication Critical patent/RS49756B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija. Prijava sadrži još 14 zavisnih patentnih zahteva.
YUP-654/01A 1999-03-11 2000-03-08 Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija RS49756B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19910986A DE19910986C2 (de) 1999-03-11 1999-03-11 Verwendung von Xenon bei der Behandlung von Neurointoxikationen

Publications (2)

Publication Number Publication Date
YU65401A YU65401A (sh) 2004-07-15
RS49756B true RS49756B (sr) 2008-04-04

Family

ID=7900688

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-654/01A RS49756B (sr) 1999-03-11 2000-03-08 Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija

Country Status (29)

Country Link
US (3) US6559190B1 (sr)
EP (1) EP1158992B2 (sr)
JP (1) JP4954373B2 (sr)
KR (1) KR100674407B1 (sr)
CN (1) CN1170544C (sr)
AR (1) AR022886A1 (sr)
AT (1) ATE248599T1 (sr)
AU (1) AU757361B2 (sr)
BG (1) BG105889A (sr)
BR (1) BR0010456A (sr)
CA (1) CA2367136C (sr)
CZ (1) CZ302864B6 (sr)
DE (2) DE19910986C2 (sr)
DK (1) DK1158992T3 (sr)
EE (1) EE200100480A (sr)
ES (1) ES2206202T5 (sr)
HK (1) HK1048073B (sr)
HU (1) HUP0201393A3 (sr)
IL (2) IL145177A0 (sr)
MD (1) MD2935C2 (sr)
NO (1) NO20014379L (sr)
PL (1) PL202941B1 (sr)
PT (1) PT1158992E (sr)
RS (1) RS49756B (sr)
RU (1) RU2246949C2 (sr)
SI (1) SI1158992T1 (sr)
SK (1) SK285111B6 (sr)
WO (1) WO2000053192A1 (sr)
ZA (1) ZA200107291B (sr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913677D0 (en) 1999-06-11 1999-08-11 Imperial College Formulation
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
DE10045829A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Volatile Anästhesiemittel mit Xenon
DE10054563A1 (de) * 2000-11-03 2002-05-16 Messer Griesheim Gmbh Verfahren und Vorrichtung zur Betonherstellung
WO2002045583A1 (en) * 2000-12-07 2002-06-13 Mclean Hospital Corporation Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
GB0209998D0 (en) 2002-05-01 2002-06-12 Protexeon Ltd Use
GB0210021D0 (en) 2002-05-01 2002-06-12 Air Prod & Chem Ultrasonic gas analyser
ES2321185T3 (es) * 2002-06-12 2009-06-03 Air Liquide Deutschland Gmbh Proteccion cerebral con un gas que contiene xenon.
AU2003249959A1 (en) * 2002-07-05 2004-01-23 Messer Griesheim Gmbh Adjuvant containing xenon
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
US7337776B2 (en) 2002-08-20 2008-03-04 Aga Ab Methods for easing pain and anxiety from atrial or ventricular defibrillation
US7681572B2 (en) 2002-08-20 2010-03-23 Aga Ab Method and devices for administration of therapeutic gases
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
BRPI0415232A (pt) * 2003-10-10 2006-12-12 Protexeon Ltd uso de xenÈnio com hipotermia para tratar asfixia neonatal
JP2007509091A (ja) * 2003-10-21 2007-04-12 エイジーエイ、アクティエボラーグ プログラム細胞死の防止のためのキセノンの使用
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1552840A1 (en) * 2004-01-07 2005-07-13 Aga Ab Use of a xenon/carbon monoxide mixture for the protection of cells
US7070005B2 (en) * 2004-02-10 2006-07-04 Planetair Turf Products, Llc Soil aerator assembly
ATE553757T1 (de) * 2004-08-02 2012-05-15 John W Olney Verhinderung von pathologischen anstiegen der nervenzellsuizidrate in unreifen nervensystemen
WO2007075100A1 (en) * 2005-12-27 2007-07-05 Zakrytoe Aktsionernoe Obshchestvo 'atom-Med Center' Method for treating drug dependence
EP1980260A1 (en) * 2007-04-10 2008-10-15 Nicholas Peter Franks Use of hyperbaric conditions to provide neuroprotection
US8435569B2 (en) * 2007-04-30 2013-05-07 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
WO2010035074A1 (en) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents
FR2952305B1 (fr) * 2009-11-10 2012-04-27 Air Liquide Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies
WO2011081612A1 (ru) * 2009-12-31 2011-07-07 Bondarenko Vitaliy Leonidovich Применение криптона или ксенона в качестве противовирусного средства
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2964036B1 (fr) 2010-08-24 2013-04-12 Air Liquide Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications
EP2672812A4 (en) * 2011-02-07 2014-09-03 Advanced Preservations Technologies Llc METHOD FOR PRESERVING CELLS AND CELL CULTURES
FR2975597B1 (fr) * 2011-05-24 2013-12-27 Air Liquide Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes
EP2760991B1 (en) 2011-09-26 2017-12-13 Rich Technologies Holding Company, LLC Method for living tissue preservation
RU2489154C1 (ru) * 2012-05-31 2013-08-10 Сергей Александрович Наумов Способ лечения вирусных гепатитов
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学***董事会 用于治疗中风的神经保护性脂质体组合物和方法
FR2996458B1 (fr) * 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996459B1 (fr) * 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996457B1 (fr) 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
PT2931291T (pt) 2012-12-11 2021-12-03 Mclean Hospital Corp Tratamento com xénon como complemento da psicoterapia para perturbações psiquiátricas
CA3132914C (en) 2013-03-15 2023-11-07 The Board Of Regents Of The University Of Texas System Liquids rich in noble gas and methods of their preparation and use
FR3007983B1 (fr) * 2013-07-08 2015-06-26 Air Liquide Association de xenon et d'un antagoniste des recepteurs nmda pour lutter contre une maladie neurodegenerative
FR3022456B1 (fr) * 2014-06-20 2016-07-15 Air Liquide Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
FR3027226B1 (fr) * 2014-10-17 2017-12-08 L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude Medicament pour traiter une maladie liee a un dysfonctionnement de la transmission synaptique dopaminergique
US10792305B2 (en) 2015-06-23 2020-10-06 Nobilis Therapeutics, Inc. Therapeutic immune modulation using noble gas compositions
EP3373940A4 (en) * 2015-11-09 2019-10-02 The McLean Hospital Corporation METHODS AND COMPOSITIONS FOR THE PREVENTION OF SUICIDE, HOMICIDE AND SELF-TREATING BEHAVIORS
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
US10485825B2 (en) * 2016-08-29 2019-11-26 Nobilis Therapeutics, Inc. Prevention of pregnancy complications by noble gas administration
US20200054671A1 (en) * 2016-10-31 2020-02-20 Nobilis Therapeutics, Inc. Treatment of anxiety disorder and augmentation of anti-anxiety interventions by administration of noble gas containing mixtures
CN107569509B (zh) * 2017-02-22 2018-09-21 滨州医学院 氙或氙气体混合物在制备治疗癫痫的制剂中的用途
CN108986622A (zh) * 2018-08-16 2018-12-11 广州迈普再生医学科技股份有限公司 一种颅内血肿微创穿刺清除术培训装置及其制备方法
RU2712804C1 (ru) * 2018-08-29 2020-01-31 Жовнерчук Инна Юрьевна Способ коррекции функционального состояния человека в замкнутом пространстве

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
US5357959A (en) * 1993-04-16 1994-10-25 Praxair Technology, Inc. Altered dipole moment magnetic resonance imaging method
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
IT1286058B1 (it) * 1996-10-29 1998-07-07 Siad Societa Italiana Acetilen Procedimento e apparecchiatura per la purificazione e recupero dello xeno e altri gas nobili in sistemi anestetici
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist

Also Published As

Publication number Publication date
DE60004974D1 (de) 2003-10-09
CZ302864B6 (cs) 2011-12-21
US20030180375A1 (en) 2003-09-25
EE200100480A (et) 2002-12-16
PT1158992E (pt) 2004-01-30
DE19910986A1 (de) 2000-09-21
JP4954373B2 (ja) 2012-06-13
EP1158992B1 (en) 2003-09-03
AU3287500A (en) 2000-09-28
AR022886A1 (es) 2002-09-04
WO2000053192A1 (en) 2000-09-14
DK1158992T3 (da) 2003-12-29
PL350618A1 (en) 2003-01-27
HUP0201393A3 (en) 2002-10-28
ES2206202T3 (es) 2004-05-16
PL202941B1 (pl) 2009-08-31
SI1158992T1 (en) 2004-02-29
NO20014379L (no) 2001-11-07
US8143317B2 (en) 2012-03-27
CA2367136A1 (en) 2000-09-14
ATE248599T1 (de) 2003-09-15
AU757361B2 (en) 2003-02-20
CN1359296A (zh) 2002-07-17
SK12792001A3 (sk) 2002-07-02
HK1048073A1 (en) 2003-03-21
JP2002538209A (ja) 2002-11-12
RU2246949C2 (ru) 2005-02-27
HK1048073B (zh) 2005-06-03
CZ20013234A3 (cs) 2002-06-12
SK285111B6 (sk) 2006-06-01
MD2935B2 (en) 2005-12-31
ZA200107291B (en) 2003-02-26
ES2206202T5 (es) 2012-05-22
BR0010456A (pt) 2002-08-27
DE60004974T3 (de) 2012-06-28
MD2935C2 (ro) 2006-08-31
DE19910986C2 (de) 2001-06-07
IL145177A (en) 2006-10-31
EP1158992A1 (en) 2001-12-05
CN1170544C (zh) 2004-10-13
BG105889A (bg) 2002-04-30
US20070110821A1 (en) 2007-05-17
CA2367136C (en) 2008-05-13
KR100674407B1 (ko) 2007-01-26
US6559190B1 (en) 2003-05-06
DE60004974T2 (de) 2004-07-22
IL145177A0 (en) 2002-06-30
NO20014379D0 (no) 2001-09-10
EP1158992B2 (en) 2012-02-01
MD20010349A (en) 2002-02-28
KR20010108338A (ko) 2001-12-07
YU65401A (sh) 2004-07-15
HUP0201393A2 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
IS6658A (is) Ný efnasambönd
IS6520A (is) Ný efnasambönd
DE60112609D1 (en) Pyrazolopyridine
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
SE9904505D0 (sv) Novel compounds
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
DK0915898T3 (da) Krystalform I af clarithromycin
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
PL367682A1 (en) Dolastatin 10 derivatives
SE9901875D0 (sv) Novel compounds
DE60112330D1 (en) Pyrazolopyridinderivate
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE0003476D0 (sv) Compounds
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
MXPA02012426A (es) Compuestos nuevos.
DE60126211D1 (de) Zementklinker, zementzusammensetzung, verfahren zur herstellung von zementklinker und verfahren zur behandlung von alkalihaltigen abfällen
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
DE69804766T2 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
IL150979A0 (en) 9-alkylamino-1-nitroacridine derivatives
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis